Probucol for mitochondrial disease with kidney problems
Treatments studied
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This program provides access to probucol, a medicine that may help with symptoms of mitochondrial disease, for people who also have chronic kidney disease. It is for those who cannot join a clinical trial.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a confirmed genetic diagnosis of mitochondrial disease.
- You have chronic kidney disease stage 3 or 4 (moderate to severe).
- You have moderate or severe symptoms from your mitochondrial disease.
- You are not eligible for or cannot access a clinical trial.
- You agree to use effective contraception if sexually active (and are not pregnant or breastfeeding).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral medication (glycerol tributyrate) in people with certain mitochondrial diseases. It aims to see if the medication can help improve symptoms by supporting energy production in cells.
This Phase 2 trial tests a treatment made from deoxynucleosides to help people with mitochondrial depletion disorder caused by certain gene changes. If you match the genetic diagnosis, the study may see whether the treatment improves symptoms or disease markers.
This trial tests a new medicine, sonlicromanol, to see if it can ease chronic fatigue and improve muscle function in people with a specific genetic condition called primary mitochondrial disease. If effective, it could offer a new treatment option to improve daily energy and quality of life.
This trial studies an oral product (a “uremic toxin” absorber) plus probiotics to help slow the progression of chronic kidney disease. It may help by lowering harmful gut-related substances that can build up when kidney function is reduced.
This study looks at immune system problems in people with mitochondrial diseases. It involves a blood draw to understand how the immune system works in these patients.
This trial tests whether the drug mercaptopurine can shrink tumors or reduce symptoms in people with HLRCC, a genetic condition that causes kidney cancer, uterine fibroids, and painful skin bumps. The study looks at the drug's effect on each of these three problems separately.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.